Palazzi, S.; Sentinelli, F.; Zugaro, A.; Morgante, S.; Santarelli, L.; Melanzi, S.; De Mutiis, A.; Piersanti, D.; Macerola, B.; Iezzi, M.;
et al. Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk. Pharmaceuticals 2025, 18, 856.
https://doi.org/10.3390/ph18060856
AMA Style
Palazzi S, Sentinelli F, Zugaro A, Morgante S, Santarelli L, Melanzi S, De Mutiis A, Piersanti D, Macerola B, Iezzi M,
et al. Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk. Pharmaceuticals. 2025; 18(6):856.
https://doi.org/10.3390/ph18060856
Chicago/Turabian Style
Palazzi, Sara, Federica Sentinelli, Antonella Zugaro, Sara Morgante, Livia Santarelli, Sandra Melanzi, Annamaria De Mutiis, Deamaria Piersanti, Barbara Macerola, Marco Iezzi,
and et al. 2025. "Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk" Pharmaceuticals 18, no. 6: 856.
https://doi.org/10.3390/ph18060856
APA Style
Palazzi, S., Sentinelli, F., Zugaro, A., Morgante, S., Santarelli, L., Melanzi, S., De Mutiis, A., Piersanti, D., Macerola, B., Iezzi, M., Mercuri, P., Ferranti, A., Tienforti, D., Cavallo, M. G., Barbonetti, A., & Baroni, M. G.
(2025). Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk. Pharmaceuticals, 18(6), 856.
https://doi.org/10.3390/ph18060856
